MSLN and neoplasm: In the case of ovarian cancer, research indicates that Mucin‐16 (MUC16) and Mesothelin (MSLN) are significant tumour antigens, presented respectively by human leukocyte antigen‐I and human leukocyte antigen‐II molecules.40